insert image

New Biomarker Pre-Screening Platform Delivers

Biomarker Positive, Trial-Ready Patients

SplashBIO™ is a new scalable biomarker platform for clinical trials for early biomarker, genetic, and cognitive testing. SplashBIO™ provides precise diagnostic, prognostic, and predictive data to ensure that potential patients are biomarker positive and trial-ready – all before their first site visit!

Here’s how SplashBIO™ can benefit your next trial:

  • Reduced Screen Failure Rates & Saved Money
  • Accelerated Enrollment
  • Improved Patient Experience
Font Resize
Colors